GGrantIndex
← Leaderboards

Erika Augustine

University Of Rochester

$6,110,416
Attributed
$6,772,122
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.6M · FY201325
$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,184,993 · 5
FDA$375,497 · 1

By mechanism

U01$3,731,631 · 1
U54$3,129,949 · 3
U24$1,323,413 · 1
R01$375,497 · 1

Top collaborators

Most similar at University Of Rochester

Same institution · by research overlap

Others in their field

Top investigators on “Rare Diseases

Research focus

Rare DiseasesClinical TrialsAffectChildhoodDesignCollaborationsProgramsEpilepsySiteNovel TherapeuticsChildEnsureFoundationsSamplingFutureSpielmeyer-Vogt DiseaseUniversitiesTraining ProgramsNeuronal Ceroid-LipofuscinosisComplexBlindnessMulticenter TrialsReadinessMotor Disorder

Grant awards (14)

Batten Disease Clinical Research Consortium$1,788,368
U54 · FY2025 · HD · contact PI
Research Project 1$984,021
U54 · FY2025 · HD · contact PI
Kennedy Krieger Institute - Johns Hopkins University NeuroNEXT Site$434,078
U24 · FY2025 · NS · contact PI
BDCRC - Administrative Core$357,560
U54 · FY2025 · HD · contact PI
Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis$610,733
U01 · FY2024 · NS · contact PI
Kennedy Krieger Institute - Johns Hopkins University NeuroNEXT Site$427,108
U24 · FY2024 · NS · contact PI
Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis$707,937
U01 · FY2023 · NS · contact PI
Kennedy Krieger Institute - Johns Hopkins University NeuroNEXT Site$462,227
U24 · FY2023 · NS · contact PI
Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis$745,729
U01 · FY2021 · NS · contact PI
Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis$747,799
U01 · FY2020 · NS · contact PI
Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis$153,983
U01 · FY2020 · NS · contact PI
Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis$765,450
U01 · FY2019 · NS · contact PI
Phase 2 of CellCept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis$176,049
R01 · FY2014 · FD · contact PI
Phase 2 of CellCept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis$199,448
R01 · FY2013 · FD · contact PI